The present disclosure relates to a bioprinter printing assembly and a bioprinter, wherein the printing assembly comprises: a support body and a rotary rod provided with a nutrient solution supply port, wherein the rotary rod is rotatably supported on the support body, a surface of the rotary rod is used for receiving bio-ink provided by a printing spray head, the rotary rod includes a hollow tube section having a central through hole, and a tube wall of the hollow tube section is provided with a permeable hole communicating with the central through hole, and the nutrient solution supply port communicates with the central through hole of the rotary rod to guide external nutrient solution into the rotary rod. The bioprinter printing assembly of the present disclosure can guide the external nutrient solution into the inside of the rotary rod through the nutrient solution supply port in the printing process, and then exudes from the permeable hole to supply the cells and biological tubular tissues on the rotary rod, thereby improving the survival rate and biological function of the cells.

A coaxial needle having two or more passageways for forming a biomimetic bioprinted blood vessel tubular construct. The coaxial needle has an external needle passageway and an internal needle passageway separated by an internal barrier, and having a nozzle at an end thereof. A bioink is provided flowable through the external needle passageway and a crosslinking solution is provided flowable through the internal needle passageway. The crosslinking solution contacts the bioink as the crosslinking solution and bioink exit the nozzle thereby forming a tubular blood vessel construct.

A veno-merse/harvester device having a handle portion, a hollow shaft portion, and a cutting portion. A fixed cannula system incorporated in the device improves the hydrostatic pressure, which allows efficient hydro-dissection with less retrograde leak of tumescent fluid and facilitates the separation of the vein from surrounding tissues with less bleeding. The veno-merse/harvester device may incorporate a camera system to allow direct visualization of the side branches to be ligated during a procedure. The self-adjustable cutting tip facilitates the forward advancement of the veno-merse/harvester device safely over a dilated portion of a vein.

A method of treating an aneurysm with an occlusion device having an inner embolic device with a proximal section and a distal section. The distal section has a first stiffness and the proximal section has a second stiffness. Further, the device has an expandable mesh capable of a collapsed position and an expanded position. The mesh can be disposed over, and attached to, a portion of the proximal section of the inner embolic device. The first stiffness is greater than the second stiffness and the inner embolic device comprises a preselected shape which assists in transforming the expandable mesh from the collapsed position to the expanded position.

In some aspects, a graft device can include a biodegradable inner layer, an outer layer, a first end portion, a second end portion, and a lumen therebetween. The biodegradable inner layer typically includes an inner surface and an outer surface. The outer layer typically includes a fiber matrix surrounding the outer surface of the inner layer. The graft device can include a reinforced end portion. At least 10% or at least 50% of the graft device can remain after 90 days of implantation. In some cases, at least 10% or at least 50% of the graft device can remain after 180 days of implantation. The graft device can include a kink-resisting element. The graft device can include at least one layer with a dynamic compliance less than or equal to at least one of: 20%/100 mmHg or 5%/100 mmHg.

Provided are systems for applying a polymer fiber matrix to a tubular conduit to create a graft device. The system comprises a polymer solution comprising at least one polymer and at least one solvent; a polymer delivery assembly constructed and arranged to receive the polymer solution and to deliver the polymer fiber matrix to the tubular conduit; a rotating assembly constructed and arranged to rotate at least one of the tubular conduit or the polymer delivery assembly; and a controller constructed and arranged to control the polymer delivery assembly and the rotating assembly. The system is constructed and arranged to reduce the amount of the solvent in the graft device. Methods of applying a polymer fiber matrix with reduced solvent are also provided.

An artificial blood vessel includes a nanofiber base film and a nanofiber external film connected to the nanofiber base film. The nanofiber base film comprises a plurality of polymer nanofibers aligned according to a first single-direction aligning pattern. The nanofiber external film comprises a plurality of polymer nanofibers aligned according to a second aligning pattern that is perpendicularly different from the first aligning pattern.

This disclosure describes decellularized, biologically-engineered tubular grafts and methods of making and using such decellularized, biologically-engineered tubular grafts.

An occlusion device for treating an aneurysm can have an inner embolic device with a proximal section and a distal section. The distal section has a first stiffness and the proximal section has a second stiffness. Further, the device has an expandable mesh capable of a collapsed position and an expanded position. The mesh can be disposed over, and attached to, a portion of the proximal section of the inner embolic device. The first stiffness is greater than the second stiffness and the inner embolic device has a preselected shape which assists in transforming the expandable mesh from the collapsed position to the expanded position.

This disclosure describes decellularized, biologically-engineered tubular grafts and methods of making and using such decellularized, biologically-engineered tubular grafts.